Literature DB >> 21527829

Replication and spread of CJD, kuru and scrapie agents in vivo and in cell culture.

Kohtaro Miyazawa1, Kaitlin Emmerling, Laura Manuelidis.   

Abstract

Transmissible Spongiform Encephalopathy (TSE) agents are defined by their virulence for particular species, their spread in the population, their incubation time to cause disease, and their neuropathological sequelae. Murine adapted human agents, including sporadic CJD (sCJD), New Guinea kuru, and Japanese CJD agents, display particularly distinct incubation times and maximal infectious brain titers. They also induce agent-specific patterns of neurodegeneration. When these TSE agents are transmitted to cultured hypothalamic GT1 cells they maintain their unique identities. Nevertheless, the human kuru (kCJD) and Japanese FU-CJD agents, as well as the sheep 22L and 263K scrapie agents display doubling times that are 8x to 33x faster in cells than in brain, indicating release from complex innate immune responses. These data are most consistent with a foreign viral structure, rather than an infectious form of host prion protein (PrP-res). Profound agent-specific inhibitory effects are also apparent in GT1 cells, and maximal titer plateau in kCJD and FU-CJD differed by 1,000-fold in a cell-based assay. Remarkably, the lower titer kCJD agent rapidly induced de novo PrP-res in GT1 cells, whereas the high titer FU-CJD agent replicated silently for multiple passages. Although PrP-res is often considered to be toxic, PrP-res instead may be part of a primal defense and/or clearance mechanism against TSE environmental agents. Limited spread of particular TSE agents through nanotubes and cell-to-cell contacts probably underlies the long peripheral phase of human CJD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21527829      PMCID: PMC3149681          DOI: 10.4161/viru.2.3.15880

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  45 in total

1.  Agent-specific Shadoo responses in transmissible encephalopathies.

Authors:  Kohtaro Miyazawa; Laura Manuelidis
Journal:  J Neuroimmune Pharmacol       Date:  2010-01-30       Impact factor: 4.147

2.  Aggregated, wild-type prion protein causes neurological dysfunction and synaptic abnormalities.

Authors:  Roberto Chiesa; Pedro Piccardo; Emiliano Biasini; Bernardino Ghetti; David A Harris
Journal:  J Neurosci       Date:  2008-12-03       Impact factor: 6.167

3.  Prions hijack tunnelling nanotubes for intercellular spread.

Authors:  Karine Gousset; Edwin Schiff; Christelle Langevin; Zrinka Marijanovic; Anna Caputo; Duncan T Browman; Nicolas Chenouard; Fabrice de Chaumont; Angelo Martino; Jost Enninga; Jean-Christophe Olivo-Marin; Daniela Männel; Chiara Zurzolo
Journal:  Nat Cell Biol       Date:  2009-02-08       Impact factor: 28.824

4.  PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.

Authors:  Song Shi; Chen-Fang Dong; Gui-Rong Wang; Xin Wang; Run An; Jian-Ming Chen; Bing Shan; Bao-Yun Zhang; Kun Xu; Qi Shi; Chan Tian; Chen Gao; Jun Han; Xiao-Ping Dong
Journal:  Virus Res       Date:  2009-01-20       Impact factor: 3.303

5.  Quantitative recovery of scrapie agent with minimal protein from highly infectious cultures.

Authors:  Ru Sun; Ying Liu; He Zhang; Laura Manuelidis
Journal:  Viral Immunol       Date:  2008-09       Impact factor: 2.257

6.  Strain-specific viral properties of variant Creutzfeldt-Jakob disease (vCJD) are encoded by the agent and not by host prion protein.

Authors:  Laura Manuelidis; Ying Liu; Brian Mullins
Journal:  J Cell Biochem       Date:  2009-02-01       Impact factor: 4.429

7.  The kuru infectious agent is a unique geographic isolate distinct from Creutzfeldt-Jakob disease and scrapie agents.

Authors:  Laura Manuelidis; Trisha Chakrabarty; Kohtaro Miyazawa; Nana-Aba Nduom; Kaitlin Emmerling
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-24       Impact factor: 11.205

8.  Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice.

Authors:  Jonathan D F Wadsworth; Susan Joiner; Jacqueline M Linehan; Melanie Desbruslais; Katie Fox; Sharon Cooper; Sabrina Cronier; Emmanuel A Asante; Simon Mead; Sebastian Brandner; Andrew F Hill; John Collinge
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-03       Impact factor: 11.205

9.  Darwinian evolution of prions in cell culture.

Authors:  Jiali Li; Shawn Browning; Sukhvir P Mahal; Anja M Oelschlegel; Charles Weissmann
Journal:  Science       Date:  2009-12-31       Impact factor: 47.728

10.  Prion strain discrimination based on rapid in vivo amplification and analysis by the cell panel assay.

Authors:  Yervand Eduard Karapetyan; Paula Saá; Sukhvir Paul Mahal; Gian Franco Sferrazza; Alexandra Sherman; Nicole Salès; Charles Weissmann; Corinne Ida Lasmézas
Journal:  PLoS One       Date:  2009-05-29       Impact factor: 3.240

View more
  10 in total

1.  Viruses do replicate in cell-free systems.

Authors:  Yervand E Karapetyan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

Review 2.  Prions on the move.

Authors:  Charles Weissmann; Jiali Li; Sukhvir P Mahal; Shawn Browning
Journal:  EMBO Rep       Date:  2011-10-28       Impact factor: 8.807

3.  Rapid chemical decontamination of infectious CJD and scrapie particles parallels treatments known to disrupt microbes and biofilms.

Authors:  Sotirios Botsios; Sarah Tittman; Laura Manuelidis
Journal:  Virulence       Date:  2015       Impact factor: 5.882

4.  Huntington's disease: lessons from prion disorders.

Authors:  Melanie Alpaugh; Francesca Cicchetti
Journal:  J Neurol       Date:  2021-02-24       Impact factor: 4.849

5.  High CJD infectivity remains after prion protein is destroyed.

Authors:  Kohtaro Miyazawa; Kaitlin Emmerling; Laura Manuelidis
Journal:  J Cell Biochem       Date:  2011-12       Impact factor: 4.429

6.  Continuous production of prions after infectious particles are eliminated: implications for Alzheimer's disease.

Authors:  Kohtaro Miyazawa; Terry Kipkorir; Sarah Tittman; Laura Manuelidis
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

7.  Reduced Expression of Prion Protein With Increased Interferon-β Fail to Limit Creutzfeldt-Jakob Disease Agent Replication in Differentiating Neuronal Cells.

Authors:  Gerard Aguilar; Nathan Pagano; Laura Manuelidis
Journal:  Front Physiol       Date:  2022-02-18       Impact factor: 4.566

8.  Susceptibility of GT1-7 cells to mouse-passaged field scrapie isolates with a long incubation.

Authors:  Kohtaro Miyazawa; Hiroyuki Okada; Yoshifumi Iwamaru; Kentaro Masujin; Takashi Yokoyama
Journal:  Prion       Date:  2014       Impact factor: 3.931

Review 9.  Infectious particles, stress, and induced prion amyloids: a unifying perspective.

Authors:  Laura Manuelidis
Journal:  Virulence       Date:  2013-04-30       Impact factor: 5.882

10.  Highly infectious CJD particles lack prion protein but contain many viral-linked peptides by LC-MS/MS.

Authors:  Terry Kipkorir; Sarah Tittman; Sotirios Botsios; Laura Manuelidis
Journal:  J Cell Biochem       Date:  2014-11       Impact factor: 4.429

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.